Eurazeo (FR:RF) has released an update.
Eurazeo has joined Naxicap Partners as a new minority shareholder in Moria, a leading company in ophthalmic microsurgery instruments, through an LBO. Moria has seen significant growth since the previous LBO in 2019, with a revenue increase from €30m to €55m and an expansion in its international market presence, especially in the United States and Asia. The company plans to continue its growth trajectory, aiming to double its activity by 2028 and solidify its market leadership through innovation and external growth strategy.
For further insights into FR:RF stock, check out TipRanks’ Stock Analysis page.
